Nephrology and Urology Devices Market Size to Reach USD 58.34 Billion by 2033 | Growing at 6.4% CAGR Driven by Rising CKD and Urological Disorders

The Nephrology and Urology Devices Market was valued at approximately USD 34.82 billion in 2024 and is projected to reach around USD 58.34 billion by 2033, growing at a CAGR of 6.4% during the forecast period 2025 to 2033. The market is expanding steadily due to the rising prevalence of chronic kidney disease, urinary tract disorders, kidney stones, benign prostatic hyperplasia, and other urological conditions worldwide.

Nephrology and urology devices include dialysis machines, urinary catheters, endoscopes, lithotripsy systems, prostate treatment devices, and minimally invasive surgical instruments used for diagnosis and treatment. Increasing aging population, growing incidence of diabetes and hypertension, and improving access to advanced healthcare infrastructure are key factors driving demand. In addition, technological advancements in minimally invasive procedures, portable dialysis systems, and robotic assisted urological surgeries are enhancing treatment outcomes and patient comfort, supporting sustained market growth globally.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/nephrology-and-urology-devices-market?sai-v

The Nephrology and Urology Devices Market refers to the global industry focused on the development and commercialization of medical devices used for the diagnosis, treatment, and management of kidney and urinary tract disorders, including dialysis systems, endoscopes, lithotripters, and catheterization devices.

Key Developments
✅ February 2026: In North America and Europe, Medtronic expanded its nephrology and urology devices portfolio with enhanced renal access and robotic-assisted urologic surgery systems, and announced plans to broaden clinical support programs and clinician training initiatives globally throughout 2026.

✅ January 2026: In global urology markets, Boston Scientific launched upgraded lithotripsy and ureteroscopy platforms with improved visualization and maneuverability, with future plans focused on AI-assisted diagnostic integration and expanded service networks in emerging regions.

✅ December 2025: In Europe and Asia Pacific, Olympus Corporation introduced advanced endoscopic and imaging devices for minimally invasive urologic procedures, and outlined expanded partnerships with major hospitals to increase adoption and procedural outcomes.

✅ November 2025: Across global renal care segments, Fresenius Medical Care strengthened its hemodialysis access and peritoneal therapy device offerings, with future initiatives to integrate remote monitoring accessories and patient-centric care solutions.

✅ October 2025: In the United States, Cook Medical expanded its portfolio of nephrology and urology interventional devices including access sheaths and drainage systems, and announced plans for expanded clinician education and post-market performance studies.

✅ September 2025: In Europe, Stryker progressed its urology surgical instrument and device innovations, optimizing ergonomics and precision for prostate and bladder procedures, with future product development aimed at enhancing minimally invasive performance.

Key Players
Medtronic plc | Baxter International Inc. | Asahi Kasei Corporation | B. Braun Melsungen AG | Boston Scientific Corporation | Coloplast A/S | Dornier MedTech GmbH | Terumo Corporation | Fresenius Medical Care AG & Co. KGaA | Nipro Corporation | Others

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=nephrology-and-urology-devices-market?sai-v
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K

Market Drivers
Increasing Prevalence of Kidney and Urinary Tract Diseases: Rising global incidence of chronic kidney disease, kidney stones, urinary incontinence, and benign prostatic hyperplasia is driving demand for advanced nephrology and urology devices.

Growth in Minimally Invasive Procedures: Preference for less invasive surgical interventions such as ureteroscopy, laser lithotripsy, and endoscopic treatments is boosting adoption of innovative device technologies.

Advancements in Diagnostic and Imaging Solutions: Development of high-resolution ultrasound systems, digital cystoscopes, and real-time imaging tools improves early detection and procedural accuracy.

Aging Population and Associated Urological Disorders: Aging demographics are increasing the requirement for devices that address age-related urological conditions, including urinary retention and pelvic floor dysfunction.

Expansion of Ambulatory Surgical Centers and Outpatient Care: Growth in outpatient and ambulatory care settings is expanding procedural volumes and increasing use of portable and user-friendly devices.

Industry Developments
Launch of Next-Generation Stone Management and Access Devices: Manufacturers are introducing advanced lithotripsy systems, flexible ureteroscopes, and single-use accessory lines that enhance efficacy and reduce procedure time.

Advancements in Robotic and Precision Surgery Platforms: Integration of robotics and enhanced control systems in urology surgery is improving outcomes for prostate, bladder, and kidney procedures.

Integration of AI and Digital Workflow Tools: AI-enabled imaging analysis, data-driven decision support, and cloud-linked procedural documentation systems are enhancing clinician efficiency.

Partnerships Between Device Makers and Healthcare Providers: Strategic collaborations are fostering training programs, integrated care pathways, and broader device adoption in hospital and outpatient settings.

Focus on Ergonomic and Patient-Friendly Designs: New device models emphasize ease of use, reduced patient discomfort, and streamlined sterilization workflows for clinical environments.

Regional Insights
North America - Holds 40 percent share: Strong healthcare infrastructure, high procedural volumes in urology and nephrology, favorable reimbursement policies, and rapid adoption of innovative devices support market leadership.

Europe - Holds 27 percent share: Established clinical guidelines, growing investment in minimally invasive technologies, and structured care networks sustain steady regional growth.

Asia Pacific - Holds 24 percent share: Expanding healthcare access in China, India, and Southeast Asia, rising disease prevalence, and increasing diagnostic and surgical procedure adoption drive growth.

Latin America - Holds 6 percent share: Improving urology and nephrology care services and growing awareness of advanced procedural options contribute to market expansion.

Middle East & Africa - Holds 3 percent share: Emerging healthcare investments, development of specialty care centers, and increasing focus on chronic disease treatment support early stage market growth.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nephrology-and-urology-devices-market?sai-v

Key Segments
By Type
Dialysis devices represent a major segment, driven by the rising prevalence of chronic kidney disease and increasing demand for hemodialysis and peritoneal dialysis systems in both hospital and homecare settings. Urinary stone treatment devices hold a significant share, supported by the growing incidence of urolithiasis and advancements in minimally invasive lithotripsy and ureteroscopy technologies. Urinary incontinence and pelvic organ prolapse devices are expanding steadily due to increasing awareness, aging population, and availability of advanced surgical meshes and supportive implants. Benign prostatic hyperplasia BPH treatment devices are witnessing strong adoption, fueled by the high prevalence of prostate enlargement among aging men and the shift toward minimally invasive procedures. Endoscopy devices play a crucial role in diagnostic and therapeutic urology, enabling precise visualization and targeted interventions within the urinary tract.

By End User
Hospitals dominate the segment owing to advanced infrastructure, availability of skilled specialists, and high patient inflow for complex nephrology and urology procedures. Ambulatory surgical centers are growing rapidly due to cost effectiveness, shorter hospital stays, and increasing preference for minimally invasive treatments. Other end users include specialty clinics and dialysis centers that provide focused renal and urological care services.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.